Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8K Sell
97
-156
-62% -$32K ﹤0.01% 846
2025
Q4
$64.8K Sell
253
-169
-40% -$44.3K 0.01% 511
2025
Q3
$110K Buy
422
+203
+93% +$53.4K 0.01% 396
2025
Q2
$53.5K Buy
219
+85
+63% +$21.2K 0.01% 536
2025
Q1
$35.5K Buy
134
+3
+2% +$811 0.01% 575
2024
Q4
$33.2K Sell
131
-52
-28% -$13.9K 0.01% 589
2024
Q3
$58K Sell
183
-181
-50% -$64.4K 0.01% 479
2024
Q2
$136K Buy
364
+311
+587% +$105K 0.02% 304
2024
Q1
$18.4K Sell
53
-134
-72% -$50.8K ﹤0.01% 658
2023
Q4
$85.6K Buy
+187
New +$92.2K 0.02% 359
2023
Q3
Sell
-221
Closed -$98.8K 555
2023
Q2
$98.8K Sell
221
-42
-16% -$21.1K 0.02% 314
2023
Q1
$128K Buy
263
+48
+22% +$23.7K 0.03% 277
2022
Q4
$110K Sell
215
-5
-2% -$2.63K 0.03% 280
2022
Q3
$107K Hold
220
0.03% 232
2022
Q2
$103K Buy
220
+25
+13% +$11.1K 0.03% 236
2022
Q1
$85K Buy
195
+85
+77% +$35.6K 0.02% 291
2021
Q4
$51K Buy
+110
New +$48.7K 0.01% 362
2021
Q3
Sell
-120
Closed -$53K 586
2021
Q2
$53K Hold
120
0.02% 355
2021
Q1
$50K Buy
+120
New +$47.9K 0.02% 275

Other funds holding HUM

CVA Family Office's HUM Position: Q1 2026 in Review

CVA Family Office reduced its Humana (HUM) stake by 62% in Q1 2026, selling an estimated $32K and leaving 97 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #846.

CVA Family Office first reported a position in HUM in Q1 2021 and has held it in 19 quarters since. The position peaked at $136K in Q2 2024. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • CVA Family Office held 97 shares of Humana worth $16.8K as of Q1 2026.
  • CVA Family Office sold 156 Humana shares in Q1 2026, an estimated $32K.
  • Humana made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #846 holding.
  • CVA Family Office first reported a position in Humana in Q1 2021 and has held it in 19 quarters since.
  • CVA Family Office's Humana position peaked at $136K in Q2 2024.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.